Last update 04 Nov 2024
Mouse nerve growth factor(Staidson (Beijing) Biopharmaceuticals Co., Ltd.)
Last update 04 Nov 2024
Overview
Basic Info
Drug Type Growth factors |
Synonyms 苏肽生 |
Target |
Mechanism p75NTR agonists(Low affinity neurotrophin receptor p75NTR agonists), Neurons stimulants |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseApproved |
First Approval Date CN (11 Apr 2006), |
Regulation- |
Login to view timeline
Related
2
Clinical Trials associated with Mouse nerve growth factor(Staidson (Beijing) Biopharmaceuticals Co., Ltd.)多中心、随机、空白对照评价注射用鼠神经生长因子用于指神经损伤后修复性再生有效性和安全性的II期临床研究
[Translation] A multicenter, randomized, blank-controlled phase II clinical study to evaluate the effectiveness and safety of injectable mouse nerve growth factor in restorative regeneration after finger nerve injury
多中心、开放、随机对照评价注射用鼠神经生长因子（苏肽生）治疗糖尿病足溃疡有效性和安全性的临床研究
[Translation] A multicenter, open, randomized controlled clinical study to evaluate the efficacy and safety of mouse nerve growth factor (Sutepsin) for injection in the treatment of diabetic foot ulcers
100 Clinical Results associated with Mouse nerve growth factor(Staidson (Beijing) Biopharmaceuticals Co., Ltd.)
Login to view more data
100 Translational Medicine associated with Mouse nerve growth factor(Staidson (Beijing) Biopharmaceuticals Co., Ltd.)
Login to view more data
100 Patents (Medical) associated with Mouse nerve growth factor(Staidson (Beijing) Biopharmaceuticals Co., Ltd.)
Login to view more data
100 Deals associated with Mouse nerve growth factor(Staidson (Beijing) Biopharmaceuticals Co., Ltd.)
Login to view more data
External Link
| KEGG | Wiki | ATC | Drug Bank |
|---|---|---|---|
| - | - | - |
R&D Status
Approved
10 top approved records. to view more data
Login
| Indication | Country/Location | Organization | Date |
|---|---|---|---|
| Optic Nerve Injuries | CN | 11 Apr 2006 |
Developing
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Nerve injury | Phase 2 | CN | 11 Jul 2018 | |
| Diabetic foot ulcer | Phase 2 | CN | 23 Sep 2017 | |
| Hepatitis B | Phase 1 | CN | 22 Aug 2022 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free